MOESM1 of Immune landscapes associated with different glioblastoma molecular subtypes

Martinez-Lage, Maria; Lynch, Timothy; Bi, Yingtao; Cocito, Carolina; Way, Gregory; Pal, Sharmistha; Haller, Josephine; Yan, Rachel; Ziober, Amy; Nguyen, Aivi; Kandpal, Manoj; Oâ€™Rourke, Donald; Greenfield, Jeffrey; Greene, Casey; Davuluri, Ramana; Dahmane, Nadia

doi:10.6084/m9.figshare.11345723.v1

40478_2019_803_MOESM1_ESM.pdf (6.05 MB)

MOESM1 of Immune landscapes associated with different glioblastoma molecular subtypes

journal contribution

posted on 2019-12-10, 05:08 authored by Maria Martinez-Lage, Timothy Lynch, Yingtao Bi, Carolina Cocito, Gregory Way, Sharmistha Pal, Josephine Haller, Rachel Yan, Amy Ziober, Aivi Nguyen, Manoj Kandpal, Donald Oâ€™Rourke, Jeffrey Greenfield, Casey Greene, Ramana Davuluri, Nadia Dahmane

Additional file 1: Figure S1. GBM tumors contain few B cells. Table S1. Clinical data and patient classification. Table S2. List of antibodies used in the study. Table S3. Results from Inform for each immune marker.

Funding

National Institute of Neurological Disorders and Stroke

History

Usage metrics

Keywords

B cells GBM Table S 1. Clinical data Immune landscapes Table S 2. List MOESM 1 patient classification Table S 3. Results

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Immune landscapes associated with different glioblastoma molecular subtypes

Funding

National Institute of Neurological Disorders and Stroke

History

Usage metrics

Categories

Keywords

Licence

Exports